Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples